Is delay of clinical worsening a valuable goal in the treatment of Alzheimer's disease?

International Journal of Geriatric Psychiatry

Volumn 27, Issue 6, 2012, Pages 657-

  Berghmans, R ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEMANTINE;

ALZHEIMER DISEASE; BACKACHE; BLOOD PRESSURE; CAREGIVER; CLINICAL DECISION MAKING; CONFUSION; CONSTIPATION; COUGHING; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG COST; DYSPNEA; FATIGUE; HALLUCINATION; HEADACHE; HUMAN; LETTER; PATIENT CARE; SIDE EFFECT; SOMNOLENCE; THERAPY DELAY; VOMITING;

ALZHEIMER DISEASE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; MALE; MEMANTINE;

EID: 84859887643     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3771     Document Type: Letter

References (1)

1. Hellweg R, Wirth Y, Janetzky W, Hartmann S,. 2011. Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD. Int J Geriatr Psychiatry (published ahead of print). DOI: 10.1002/gps.2766